Please Wait
Applying Filters...
Menu
Xls
2D Structure
Also known as: Alm301, 1313439-71-2, Vad044, Vad-044, K2us8hw4tq, Chembl5314970
Molecular Formula
C25H25N3O3
Molecular Weight
415.5  g/mol
InChI Key
BPHCAPAOSHZYJY-UHFFFAOYSA-N
FDA UNII
K2US8HW4TQ

VAD-044 is an allosteric AKT inhibitor developed by Vaderis Therapeutics AG. It is being investigated for the treatment of Hereditary Hemorrhagic Telangiectasia.
1 2D Structure

2D Structure

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
6-[4-(1-amino-3-hydroxycyclobutyl)phenyl]-1-ethyl-7-phenylpyrido[2,3-b][1,4]oxazin-2-one
2.1.2 InChI
InChI=1S/C25H25N3O3/c1-2-28-21-12-20(16-6-4-3-5-7-16)23(27-24(21)31-15-22(28)30)17-8-10-18(11-9-17)25(26)13-19(29)14-25/h3-12,19,29H,2,13-15,26H2,1H3
2.1.3 InChI Key
BPHCAPAOSHZYJY-UHFFFAOYSA-N
2.2 Other Identifiers
2.2.1 UNII
K2US8HW4TQ
2.3 Synonyms
2.3.1 Depositor-Supplied Synonyms

1. Alm301

2. 1313439-71-2

3. Vad044

4. Vad-044

5. K2us8hw4tq

6. Chembl5314970

7. Schembl12506659

8. Schembl14917320

9. Ex-a7217

10. At43335

11. Da-60932

12. Ms-27212

13. Hy-151504

14. Cs-0614399

15. 1h-pyrido[2,3-b][1,4]oxazin-2(3h)-one, 6-[4-(cis-1-amino-3-hydroxycyclobutyl)phenyl]-1-ethyl-7-phenyl-

2.4 Create Date
2012-11-30
3 Chemical and Physical Properties
Molecular Weight 415.5 g/mol
Molecular Formula C25H25N3O3
XLogP32.6
Hydrogen Bond Donor Count2
Hydrogen Bond Acceptor Count5
Rotatable Bond Count4
Exact Mass g/mol
Monoisotopic Mass g/mol
Topological Polar Surface Area88.7
Heavy Atom Count31
Formal Charge0
Complexity638
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1